A biopharmaceutical company focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics designed to improve patient diagnosis, treatment and management.
The best Bull and Bear pitches based on recency and number of recommendations.
The company currently has no drugs on the market which I would imagine no product on the market + expenses = low or declining stock price short term, however,Their two oncology drugs Azedra and Onalta both have orphan drug status which will allow… More
MIPI has a too high valuation compared to its sales potential. It is also very loss making at least until 2011.
Read the most recent pitches from players about MIPIQ.
Find the members with the highest scoring picks in MIPIQ.
adambward (57.09) Score: +500.91
The Score Leader is the player with the highest score across all their picks in MIPIQ.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| adambward | 57.09 | 6/18/2009 |
|
3W | $6.95 | -99.94% | +400.97% | +500.91 | 0 Comment | |
| SirCharms | 21.13 | 6/10/2009 |
|
5Y | $4.47 | -99.91% | +381.13% | +481.03 | 0 Comment | |
| dexxyru | 75.44 | 11/2/2009 |
|
5Y | $4.35 | -99.91% | +339.07% | +438.97 | 0 Comment | |
| anticitrademix | < 20 | 11/2/2009 |
|
5Y | $4.85 | -99.92% | +336.58% | +436.49 | 0 Comment | |
| anticitrademix2 | < 20 | 11/2/2009 |
|
5Y | $4.85 | -99.92% | +336.58% | +436.49 | 0 Comment | |
| payroll1 | 82.30 | 5/12/2008 |
|
5Y | $7.35 | -99.94% | +238.57% | +338.52 | 0 Comment | |
| sac3 | 86.14 | 8/23/2007 |
|
NS | $6.90 | -99.94% | +224.79% | +324.73 | 0 Comment | |
| Styex | 64.03 | 7/31/2007 |
|
NS | $8.00 | -99.95% | +222.63% | +322.57 | 0 Comment | |
| phalayko | 85.56 | 9/28/2007 |
|
3M | $6.82 | -99.94% | +211.62% | +311.56 | 0 Comment | |
| crossbreed | 61.41 | 7/13/2007 |
|
1Y | $9.12 | -99.96% | +209.61% | +309.56 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
